We therefore conducted a sensitivity analysis excluding this trial from the primary meta-analysis
7 In 1993, a German laboratory confirmed what Engs paper had implied: exendin-4 was not merely structurally similar to GLP-1 it was a high-potency agonist at the human GLP-1 receptor, stimulating the same cAMP signaling cascade in insulin-secreting beta cells and amplifying glucose-induced insulin secretion
Lack of monitoring : Individuals self-adjusting doses may not receive appropriate clinical monitoring for adverse effects or treatment response
However, if taken by mouth, the digestive system would break it down before it could be absorbed effectively
8,536,122 was filed on March 5, 2012, and was granted on September 17, 2013
Package: 1,5,10,25kg/bag or 25kg/drum